JP Stock MarketDetailed Quotes

4893 Noile-Immune Biotech

Watchlist
  • 212
  • +9+4.43%
20min DelayMarket Closed Aug 19 15:00 JST
9.18BMarket Cap-7779P/E (Static)

Noile-Immune Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Noile-Immune Biotech Q2 2024 Earnings Date

Currency：JPYAug 9, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
0
0
+2.59M
Beat Est.
-100.00%
-100.00%
--
EPS
0
-7.93
-15.79
Miss Est.
+100.00%
+7.14%
--
Analyst Rating
Strong Buy

Dec 19, 2023

Noile-Immune Biotech Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 0 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
May 14, 20242024/Q12.000M / ----
Nov 13, 20232023/Q3303.000M / ----
DatePeriodRevenue/EstimateEarnings Call
May 14, 20242024/Q12.000M / ----
Nov 13, 20232023/Q3303.000M / ----
--------
--------
--------

Unlock Free Earnings Estimates

Noile-Immune Biotech Earnings Reports

  • Noile-Immune Biotech: Semi-Annual Report - Term 10 (2024/01/01 - 2024/12/31)

    Aug 12 23:02 ET

  • Noile-Immune Biotech: Confirmatory letter.

    Aug 12 23:00 ET

  • Noile-Immune Biotech: 2nd quarter (interim) financial report for the fiscal year ending December 2024 [Japan Standard] (non-consolidated)

    Aug 9 04:45 ET

  • Noile-Immune Biotech: Confirmation letter

    May 14 04:07 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 19, 2023

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    % Chg